tirzepatide surmount 4 Direct Link to JAMA Post Hoc Analysis of SURMOUNT-4: Cardiometabolic Parameter Change by Weight Regain on Withdrawal in Adults With Obesity : r/Zepbound SURMOUNT‐4 study design. This is

health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisks Wegovy and Eli Lillys Zepbound.

Third-party tested potency, heavy metals, microbials

Chronic blood loss from gastrointestinal bleeding MANAGEMENT Iron deficiency anemia is managed with iron supplementation (oral or intravenous), dietary modifications, and addressing the cause of blood loss

See real before-and-after transformations, improved metabolic health, and long-term weight stabilization

People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review of 63 trials covering over 9,000 individuals showed.

Conclusions Oral semaglutide demonstrates superior efficacy in reducing HbA1c levels and a rapid onset of action in Asian patients